🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🖥️Are you curious about how AI can help in clinical practice? Find out more about Histopathology Explorer, the largest publicly available dashboard of AI-based histopathology studies, in this guide with Heba Sailem, PhD >>> oncology-central.com/histopathexplo…

This free eBook explores breast cancer survivorship through the lens of mental health, fertility and quality of life. Access it here 👉 hubs.ly/Q03mvYq80 #ESMOBreast2025 #BreastCancerSurvivorship

Scientists and medics from UoN Life Sciences & UoN Medicine and Health Sciences & NUH Medicine have developed an ultra-rapid method of genetically diagnosing brain tumors, which could cut the time it takes to classify them from 2 months to as little as 2 hours >>> hubs.ly/Q03nJ1S70

The INAVO120 trial continues to inform treatment strategies for advanced breast cancer. Final data presented at #ASCO25 show improvement in median overall survival, adding to previous findings on progression-free survival that supported the US FDA approval of the combination in

Research being presented at #ASCO25 demonstrates the potential of GLP-1 agonists in reducing the risk of 14 obesity-related cancers in people with diabetes >>>oncology-central.com/asco-2025-glp-…

Research presented at #ASCO2025 reveals how AI can assist pathologists in accurately identifying HER2-low and HER2-ultralow breast cancers and reduce the rate of misclassification >>> @Marina De Brot 🗣️“Our study provides the first multinational evidence that artificial

What is RBness and how could "big data" advance #TNBC drug discovery? Find out in our interview with researchers from The ICR >>> hubs.ly/Q03lm-1f0 Breast Cancer Now Cancer Research UK #TNBC #BCSM

The world's premier oncology conference is just a day away, featuring 6,000+ groundbreaking abstracts that could reshape cancer care. We've curated the essential news headlines and key themes in one handy article >>> oncology-central.com/asco-2025-guid… #ASCO25

Your guide to #ASCO25 is here! We've compiled the breaking news headlines and themes from oncology's largest conference into one essential guide >>> oncology-central.com/asco-2025-guid…

Dr Carmen Calfa (Sylvester Comprehensive Cancer Center) recently presented data at #ASCO25 on Bria-IMT combined with checkpoint inhibitors in metastatic breast cancer. In this interview, she shares her top takeaways, explains the significance of HLA matching and offers thoughtful advice to

In our latest interview, Carmen Calfa (Sylvester Comprehensive Cancer Center) breaks down clinical outcomes from her ASCO presentation on Bria-IMT + checkpoint inhibitors in MBC >>> hubs.ly/Q03qlcJY0

Dr. Carmen Calfa, MD joined Oncology Central to discuss her poster presentation at #ASCO25, which highlighted survival results for Bria-IMT + checkpoint inhibitors for metastatic breast cancer (MBC) patients. Read key takeaways from her #research, the impact of HLA matching on

Did you catch #ESMOBreast25 in Munich? 💬 Over 3,500 attendees, major updates and multidisciplinary insights. 📰 Read our Editor’s Highlights: hubs.ly/Q03rdMXP0

The #AOSW2025 Annual Conference is almost here! We asked AOSW President Linda Mathew to share her top session picks. Don't miss these must-see presentations in Atlanta, June 11–13. 🗓️ >>> hubs.ly/Q03rwSqL0

The Oncology Central team recently returned from the ESMO Breast Cancer Congress 2025 in Munich! 🎗️ With over 3,500 attendees, the event offered a wealth of knowledge and innovation in breast cancer care and research. 📖 Read our Editor’s Highlights from the event:

Results of the SERENA-6 trial, presented ASCO, revealed that a treatment regimen including camizestrant can be used to treat emerging breast tumors, months before they progress >>> hubs.ly/Q03rFYmz0 Nicholas Turner🗣️“This is a pivotal moment in breast cancer care. These

💡To mark the beginning of the the #AOSW2025 Annual Conference, we spoke with AOSW President Linda Mathews (Memorial Sloane Kettering) to highlight her top session recommendations. hubs.ly/Q03rw-Nq0

Mark your calendars! The 18th Annual Royal Marsden Breast Cancer Meeting returns to London on October 3rd. Join fellow clinicians and nurses for the latest in breast cancer research and care. Register now: hubs.ly/Q03twQRd0 #BCSM

Researchers from the Cambridge University have developed a new capsule sponge test for monitoring Barrett’s esophagus, a known precursor to esophageal cancer. This method is far less invasive and easier-to-administer than current endocopic surveillance methods >>>

With the 2nd Breast Cancer UK Breast Cancer Prevention Conference wrapped up, we’re here to provide you with the key themes and highlights from the event >>> bit.ly/4lzBmDA